Media Alert: Atossa Genetics to Sponsor Screenings of Decoding Annie Parker at the Seattle International Film Festival on June 6 and 8, 2013
May 29, 2013 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - May 29, 2013) - Atossa Genetics, Inc.
WHAT:
Based on true events, Decoding Annie Parker follows a 15-year war waged on both scientific and emotional...
Atossa Genetics Reports First Quarter 2013 Results and Operating Highlights
May 15, 2013 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - May 15, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company™, today announced its first quarter 2013 financial results and corporate...
Atossa Genetics to Present at the Sachs Associates Cancer Bio Partnering Forum and Participate on the Cancer Tech Panel
May 14, 2013 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - May 14, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Dr. Steven Quay, Chairman, CEO & President, will speak...
Atossa Genetics and Clarity Women's Health Announce U.S. Launch of the ForeCYTE Breast Health Test
January 14, 2013 08:00 ET
|
Atossa Genetics, Inc.
BOCA RATON, FL--(Marketwire - Jan 14, 2013) - Atossa Genetics (NASDAQ: ATOS), the Breast Health Company™, based in Seattle, Washington, and Clarity Women's Health (a division of Diagnostic...
The International Society for Cancer Risk Assessment and Management (ISC-RAM) Announces First Inaugural Meeting
December 03, 2012 08:00 ET
|
Atossa Genetics, Inc.; International Society for Cancer Risk Assessment (ISC-RAM)
NEW YORK, NY--(Marketwire - Dec 3, 2012) - The International Society for Cancer Risk Assessment and Management (ISC-RAM) is the first international, collaborative, multidisciplinary group whose...
Atossa Genetics Acquires Rights to Patents Covering a Novel Screening Test for Breast Cancer From the Dr. Susan Love Research Foundation
July 13, 2011 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - Jul 13, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Atossa Genetics Completes $6.6 Million Over-Subscribed Private Placement
June 27, 2011 08:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - Jun 27, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Atossa Genetics, Inc. and HLB, LLC Announce Partnership to Manufacture Atossa's Patented, FDA-Cleared MASCT System for Breast Cancer Risk Assessment
May 03, 2011 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA and CHICAGO, IL--(Marketwire - May 3, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular...
Atossa Genetics Appoints Tim Hunkapiller, Ph.D., to Its Scientific Advisory Board
April 14, 2011 11:28 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - Apr 14, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Steven C. Quay, M.D., Ph.D., of Atossa Genetics Elected as a Fellow of the College of American Pathologists
March 14, 2011 08:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - March 14, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...